Skip to main content
. 2018 Jan 5;15(3):2688–2692. doi: 10.3892/etm.2018.5712

Table I.

Clinical status of each of the 19 patients.

SCr (µmol/l) BUN (mmol/l)
Subject no. Sex Age (years) Initial PPC (mg/l) Initial UPC (mg/l) Time between poisoning and HP therapy (h) Duration of activated charcoal HP therapy (h) Prior to HP After HP At discharge Prior to HP After HP At discharge Outcome
1 Male 39   5.7   9.2 7 18 69   62 258 5.1 4.5 12.9 Death
2 Male 28   6.3 12.1 5 17 64   94 100 4.0 6.5   6.8 Death
3 Female 30 10.1 21.7 6 20 63   91 228 3.5 5.1 14.1 Death
4 Female 54   6.5 15.7 6 17 68   57 135 6.5 9.5 13.1 Death
5 Male 30   2.1   4.4 8 14 76   79   99 5.8 5.1 13.5 Survival
6 Female 39   4.6 11.2 10 16 32 112   53 4.2 8.5   7.0 Survival
7 Female 49   2.3   6.2 8.5 17 31   45   78 3.5 2.6 10.9 Survival
8 Female 56   1.6   2.8 9 16 49   86   84 6.3 7.8   9.4 Survival
9 Male 58   9.8 18.6   5.5 23 85   84 208 7.9 9.3 13.5 Death
10 Male 25 11.8 23.7 7 16 57 109 153 4.0 6.4 10.6 Death
11 Female 48     1.45   3.5 5   8 46   38   51 5.7 5.3   6.8 Survival
12 Male 47   4.1   6.1 10.5 17 70 101 188 5.1 8.9 11.2 Death
13 Female 25   0.1   0.7 4.5   6 45 38   49 3.7 7.0   3.5 Survival
14 Female 29   3.1   4.5 6.5 12 72   57   86 5.4 6.8   8.1 Survival
15 Male 33   2.2   3.5 8 14 45   46   46 2.9 2.4   6.3 Survival
16 Male 63   3.6   6.1 9 18 45   74 145 5.4 7.0 14.1 Survival
17 Male 36   3.5   6.9 5.5 14 78   75   82 4.6 4.7   6.3 Survival
18 Male 50   1.1   1.7 11   8 48   49   62 3.7 4.6   5.6 Survival
19 Male 26   4.3 16.7 6.5   6 69   92   88 4.5 3.5   7.6 Survival

BUN, blood urea nitrogen (normal range, 3.2–7.1 mmol/l); SCr, serum creatinine (normal range, 71–133 µmol/l); UPC, urine paraquat concentration; PPC, plasma paraquat concentration; HP, charcoal hemoperfusion.